4.7 Article

Molecular Characterization of Human Respiratory Syncytial Virus Subtype B: A Novel Genotype of Subtype B Circulating in China

期刊

JOURNAL OF MEDICAL VIROLOGY
卷 87, 期 1, 页码 1-9

出版社

WILEY
DOI: 10.1002/jmv.23960

关键词

human respiratory syncytial virus; subtype B; genotype; GB5; G glycoprotein; China

类别

资金

  1. China Special Grant for the Prevention and Control of Infection Diseases [2013ZX10004202-002]

向作者/读者索取更多资源

Human respiratory syncytial virus (HRSV) is major pathogen of lower respiratory tract infections in infants and young children worldwide. There have been many studies regarding HRSV subgroup A (HRSV-A) G protein genetic variability but little information about HRSV subtype B (HRSV-B) G protein genetic diversity and molecular evolution in China. Thus, a survey of the molecular epidemiology and evolution of the G protein in China is of high importance. In this study, the circulation and genetic diversity of HRSV in Chongqing, Southwestern China, from June 2009 to May 2013, were investigated. A total of 3,167 nasopharyngeal aspirates were obtained in this study, and it was found that HRSV-B predominated in the 2009-2010 and 2012-2013 epidemic seasons. This study identified the genetic variability of the glycoprotein G gene among 102 HRSV-B strains isolated by cell culture from Chongqing nasopharyngeal aspirates, and 68 Chinese HRSV-B sequences were deposited in GenBank. Genotyping and phylogenetic analysis revealed that the HRSV-B strains were clustered into three genotypes: BA (n=111, 65.29%), GB3 (n=5, 2.94%), and a new GB genotype (n=54, 31.77%) named GB5. The GB5 strains varied from other genotypes in the central conserved region and N-glycosylation sites. The estimated evolutionary rate of Chinese HRSV-B was 2.01x10(-3) nucleotide substitutions/site/year, which is similar to the reports from Belgium and the Netherlands with 1.95x10(-3) and 2.78x10(-3) nucleotide substitutions/site/year, respectively. This study provides data on the circulating pattern and molecular characterization of HRSV-B genotypes in China during four consecutive years and may contribute to HRSV vaccine development. J. Med. Virol. 87: 1-9, 2015. (c) 2014 Wiley Periodicals, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据